ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #17,117Diamond OAGold OA

Arterial Hypertension

Identifier (ISSN):2449-6170(Print)/2449-6162(Online)
•
Publisher:VM Media sp. z o.o. VM Group sp.k. Grupa Via Medica
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.9↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Arterial Hypertension

WoS Q4
01120.720230.420240.620250.92026
Annual Impact Factor Metric
Current (2026):0.9
Scopus SJR & RankScopus Q3
0.302
#17,117

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
14

14 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
19articles/year
100% Gold OA•70.83% Original Research

Aims & Scope

Arterial Hypertension hereinafter referred to as ‘AH’ or ′the Journal′, is a peer-reviewed, open access journal covering broad spectrum of topics in hypertension and aiming to advance the knowledge and science of this constantly evolving field. The Journal is the official quarterly of the Polish Society of Hypertension and publishes review articles, original clinical and experimental investigations in the field of arterial hypertension, case reports, letters and editorial comments. The Journal's content has been published predominantly in full text English since 2015.

Topics Covered (Recognized by AI)
Medicine86.8%Internal medicine69.4%Biology49.1%Endocrinology43.8%Physics41.9%Radiology28.8%Cardiology28.4%Blood pressure27.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PERIPHERAL VASCULAR DISEASE

Q4
Rank87/100
IndexESCI
JCIESCI2026

PERIPHERAL VASCULAR DISEASE

Q4
Rank85/100
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.9
Articles / Year6
Total Citations0
2025
IF0.6
Articles / Year16
Total Citations2
2024
IF0.4
Articles / Year13
Total Citations16
2023
IF0.7
Articles / Year29
Total Citations36
2022
IF—
Articles / Year29
Total Citations134

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,117Scopus Q3Diamond OASCImago Profile
Scopus Coverage:2015-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.302

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.74

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations64
3-Year Documents65
Citable Documents63

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate62.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ3
Internal MedicineQ3
Endocrinology, Diabetes and MetabolismQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PERIPHERAL VASCULAR DISEASE
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Arterial Hypertension (ISSN: 2449-6170) is a peer-reviewed international scholarly journal in the field of PERIPHERAL VASCULAR DISEASE, published by VM Media sp. z o.o. VM Group sp.k. Grupa Via Medica in Poland. The periodical holds a Journal Impact Factor (JIF) of 0.90, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.302 (Q3), an H-index of 14.

The journal enforces rigorous peer evaluation with an annual output of approximately 19 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
VM Media sp. z o.o. VM Group sp.k. Grupa Via Medica
Publication Language
English, Polish
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c271d5a2-553f-4c42-98ce-f3485f5dadec
Database Updated: 2026-10-01